Eric Reynolds compensation by year
Clorox Summary Compensation Table · all 5 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Salary | $700,000 | $729,231 | $768,462 | $793,538 | $806,923 |
| Bonus | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $1,679,713 | $1,839,792 | $1,999,819 | $2,799,821 | $2,999,828 |
| Option awards | $420,084 | $459,998 | $499,974 | $0 | $0 |
| Non-equity incentive | $720,300 | $370,000 | $1,390,830 | $819,000 | $684,600 |
| Pension and deferred compensation | $2,245 | $1,844 | $2,869 | $1,758 | $418 |
| All other | $286,907 | $239,785 | $192,340 | $351,627 | $271,097 |
| Total | $3,809,250 | $3,640,651 | $4,854,294 | $4,765,745 | $4,762,866 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: The Clorox Company DEF 14A filed October 7, 2025, accession 0001552781-25-000311, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 15,337 | $1,841,514 | — |
| PSU | 12,903 | $1,549,263 | — |
| PSU | 11,200 | $1,344,784 | — |
| PSU | 7,466 | $896,443 | — |
| PSU | 6,168 | $740,592 | — |
| PSU | 1,793 | $215,286 | — |
| PSU | 701 | $84,169 | — |
| Option | 9,273 | — | $141.30 |
| Option | 5,164 | — | $163.77 |
Per the Outstanding Equity Awards at Fiscal Year-End table in The Clorox Company's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
4 Form 4 lines since the FY2025 proxy (filed October 7, 2025)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-12-12 | Tax withholding | — | 255 | $102.83 | 69,058 |
| 2025-10-03 | Grant or award | — | 15,489 | $122.25 | 79,504 |
| 2025-10-03 | Tax withholding | — | 2,755 | $122.25 | 76,749 |
| 2025-10-03 | Tax withholding | — | 7,436 | $122.25 | 69,313 |
The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Clorox discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $7,898,871 | $0 | $7,898,872 |
| Retirement | $0 | $7,898,871 | $0 | $7,898,872 |
| Disability | $0 | $7,898,871 | $0 | $7,898,872 |
| Change in control and involuntary termination | $4,197,250 | $7,898,871 | $15,708 | $12,130,829 |
| Involuntary termination without cause | $2,485,750 | $7,898,871 | $15,708 | $10,400,329 |
| Voluntary resignation | $0 | $7,898,871 | $0 | $7,898,872 |
Per the Potential Payments Upon Termination or Change in Control table in The Clorox Company's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Clorox’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Linda Rendle | Chair and Chief Executive Officer (CEO) | $13,333,032 |
| Nina Barton | EVP and Group President–Care & Connection | $10,070,862 |
| Eric Reynolds · this page | EVP and Chief Operating & Strategy Officer | $4,762,866 |
| Chris Hyder | EVP and Group President–Health & Hygiene | $4,366,368 |
| Kevin Jacobsen | Former EVP and Chief Financial Officer | $4,246,342 |
| Luc Bellet | EVP and Chief Financial Officer (CFO) | $2,622,295 |
The full Clorox compensation record
free company briefThis page is one person within Clorox's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Clorox's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Clorox's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat